Posts Tagged ‘AIT Therapeutics’
Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement
Sichenzia Ross Ference LLP Congratulates AIT Therapeutics, Inc. on NASDAQ Uplisting
New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented AIT Therapeutics, Inc. (NASDAQ: AITB), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Avital Perlman. The uplisting is effective for trading…
Read More